Effect of Empagliflozin Treatment on Ventricular Repolarization Parameters

Effect of Empagliflozin Treatment on Ventricular Repolarization Parameters

Background: An example of a sodium-glucose cotransporter-2 (SGLT-2) inhibitor is Empagliflozin. It is a new medicine for treating type 2 diabetes mellitus (T2DM), but there is increasing interest in how empagliflozin affects the heart. This study aims to examine the impact of empagliflozin treatment...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Fatih Ozturk, Hasim Tuner, Adem Atici, Hasan Ali Barman
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	IMR Press 2024-02-01
Loạt:	Reviews in Cardiovascular Medicine
Những chủ đề:	empagliflozin type 2 diabetes mellitus ventricular repolarization qt interval arrhythmias sglt-2 inhibitor
Truy cập trực tuyến:	https://www.imrpress.com/journal/RCM/25/2/10.31083/j.rcm2502064

Những quyển sách tương tự

The Effect of Renal Transplantation on Ventricular Repolarization in Children with Chronic Renal Failure
Bằng: H Amoozgar, et al.
Được phát hành: (2013-10-01)

Analysis of 24-h Rhythm in Ventricular Repolarization Identifies QT Diurnality As a Novel Clinical Parameter Associated with Previous Ventricular Arrhythmias in Heart Failure Patients
Bằng: Bastiaan C. Du Pre, et al.
Được phát hành: (2017-08-01)

Comparison of Extraglycemic effects of Dapagliflozin and Empagliflozin
Bằng: Haroon Aziz, et al.
Được phát hành: (2023-06-01)

Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts
Bằng: Julian Wolfes, et al.
Được phát hành: (2024-02-01)

Corrigendum: Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts
Bằng: Julian Wolfes, et al.
Được phát hành: (2025-02-01)

Postextrasystolic Repolarization Abnormalities in ST‐U Segment in Patients with Ventricular Arrhythmias
Bằng: Maria Trusz‐Gluza, et al.
Được phát hành: (2001-01-01)

Empagliflozin’s role in reducing ventricular repolarization heterogeneity: insights into cardiovascular mortality decline from the EMPATHY-HEART trial
Bằng: Cristiane Lauretti, et al.
Được phát hành: (2024-06-01)

The effect of hemodialysis adequacy on ventricular repolarization in end-stage kidney disease
Bằng: Belma Kalaycı, et al.
Được phát hành: (2019-10-01)

A Study on the Diurnal Variation of Ventricular Repolarization Parameters in Patients with Obstructive Sleep Apnea
Bằng: YANG Beibei, JIANG Junguang, SHI Jiang, ZHANG Yang
Được phát hành: (2022-01-01)

Depolarization and repolarization dynamics after His‐bundle pacing: Comparison with right ventricular pacing and native ventricular conduction
Bằng: Satoshi Yanagisawa, et al.
Được phát hành: (2022-09-01)

Empagliflozin: a potential anticancer drug
Bằng: Wenwen Wu, et al.
Được phát hành: (2023-07-01)

The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
Bằng: Diana Alegre-González, et al.
Được phát hành: (2025-10-01)

Association Between Left Atrial Volume Index and Ventricular Repolarization Heterogeneity: A Cross-Sectional Study of a Healthy Chinese Population
Bằng: Li Z, et al.
Được phát hành: (2021-05-01)

Effects of empagliflozin on reproductive system in men without diabetes
Bằng: Christophe Kosinski, et al.
Được phát hành: (2024-06-01)

Prevalence and QT Interval of Early Repolarization in a Hospital-based Population
Bằng: Hideki Hayashi, MD PhD, et al.
Được phát hành: (2010-01-01)

Effects of Prediabetes on Ventricular Repolarization Markers in Electrocardiography
Bằng: Tolga Memioğlu, et al.
Được phát hành: (2025-02-01)

Psychological factors and cardiac repolarization instability during anger in implantable cardioverter defibrillator patients
Bằng: David S. Krantz, et al.
Được phát hành: (2021-07-01)

Empagliflozin: a wonder drug for the treatment of SIAD?
Bằng: Ploutarchos Tzoulis
Được phát hành: (2024-10-01)

Effect of Methadone on Cardiac Repolarization in Japanese Cancer Patients: A Longitudinal Study
Bằng: Eriko Yamanaka, et al.
Được phát hành: (2019-11-01)

Empagliflozin in type 1 diabetes
Bằng: Mathieu C, et al.
Được phát hành: (2019-08-01)

Noninvasive Mapping of Repolarization With Electrocardiographic Imaging
Bằng: Yoram Rudy
Được phát hành: (2021-05-01)

Electrocardiographic manifestations of COVID-19: Effect on cardiac activation and repolarization
Bằng: Avni Thakore, et al.
Được phát hành: (2021-09-01)

Effect of long-term use of antipsychotics on the ventricular repolarization index
Bằng: Qiong Liu, et al.
Được phát hành: (2024-07-01)

Assessment of Ventricular Repolarization in Sickle Cell Anemia Patients: The Role of QTc Interval, Tp-e Interval and Tp-e/QTc Ratio and Its Gender Implication
Bằng: Ajibare AO, et al.
Được phát hành: (2020-12-01)

Influence of aging and chronic heart failure on temporal dispersion of myocardial repolarization
Bằng: Piccirillo G, et al.
Được phát hành: (2013-03-01)

Empagliflozin and the Prevention of Heart Failure
Bằng: Douglas L. Mann, MD, et al.
Được phát hành: (2017-08-01)

Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial
Bằng: Shinya Fujiki, et al.
Được phát hành: (2024-06-01)

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
Bằng: Zhaoyang Hu, et al.
Được phát hành: (2021-10-01)

Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis
Bằng: Zepeng Shi, et al.
Được phát hành: (2022-04-01)

The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications
Bằng: Wael Abu Dayyih, et al.
Được phát hành: (2024-03-01)

Influence of Diabetes Mellitus on myocardial repolarization by measurement of QT variability Index
Bằng: Abbas F. Al-Hashimi, et al.
Được phát hành: (2011-10-01)

Repolarization reserve, arrhythmia and new drug development
Bằng: Yang Li, et al.
Được phát hành: (2013-05-01)

Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease
Bằng: Pasquale Mone, et al.
Được phát hành: (2024-02-01)

Empagliflozin: a new strategy for nephroprotection in diabetes
Bằng: Anton Ivanovich Korbut, et al.
Được phát hành: (2017-05-01)

Association between Empagliflozin Use and Electrocardiographic Changes
Bằng: Daniel Antwi-Amoabeng, et al.
Được phát hành: (2022-07-01)

Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA‐REG OUTCOME trial
Bằng: David Fitchett, et al.
Được phát hành: (2021-12-01)

The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
Bằng: Hsiang-Chun Lee, et al.
Được phát hành: (2019-04-01)

Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
Bằng: Mikkel Jürgens, et al.
Được phát hành: (2021-08-01)

Short-Term Treatment with Empagliflozin Resulted in Dehydration and Cardiac Arrest in an Elderly Patient with Specific Complications: A Case Report and Literature Review
Bằng: Sopak Supakul, et al.
Được phát hành: (2022-06-01)

Case Report: Diabetic ketoacidosis after co-administration of empagliflozin and probenecid [version 2; peer review: 2 approved, 1 approved with reservations]
Bằng: Niamh Reidy, et al.
Được phát hành: (2024-03-01)